Recalls / Class II
Class IID-0003-2026
Product
Bevacizumab 1.75 mg/0.07 mL - 0.25 mL syringe, Intravitreal, 0.07 mL Total Volume, Rx Only, Hospital/Office Use Only, Refrigerate, RC Outsourcing LLC, Lowellville, OH 44436.
- Affected lot / code info
- Lot # 20250708-768A26, BUD: Oct 06, 2025 20250715-944DF2 BUD: Oct 13, 2025 20250722-55C603 BUD: Oct 20, 2025 20250722-5DC113 BUD: Oct 20, 2025
Why it was recalled
Lack of assurance of sterility.
Recalling firm
- Firm
- RC Outsourcing, LLC
- Notification channel
- Letter
- Type
- Voluntary: Firm initiated
- Address
- 102 E Water St, Lowellville, Ohio 44436-1117
Distribution
- Quantity
- 2,669 syringes
- Distribution pattern
- Nationwide in the US
Timeline
- Recall initiated
- 2025-09-22
- FDA classified
- 2025-10-06
- Posted by FDA
- 2025-10-15
- Terminated
- 2026-01-05
- Status
- Terminated
Source: openFDA Drug Enforcement endpoint. Recall record D-0003-2026. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.